Literature DB >> 2142455

Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.

E L Larsson-Sciard1, A L Spetz-Hagberg, A Casrouge, P Kourilsky.   

Abstract

The usage of four different T cell receptor (TcR) V beta gene families within normal, non-primed T cell populations in response to various types of antigen-presenting cells (APC) in primary mixed lymphocyte reaction has been studied. We demonstrate that distinct patterns of V beta gene usage are obtained within a given T cell population in response to different types of APC with the same allo-H-2. When responder T cells are stimulated with one type of allogeneic APC, from various H-2-disparate mice, the same V beta gene preference is observed. Furthermore, when H-2- and Mls-mismatched APC gene used as stimulators, the Mls-associated V beta 6 and V beta 8.1 gene families are highly elevated in response to both B and T cell blasts from certain Mls-positive strains. The results demonstrate that different types of allogeneic APC have the capacity to generate biases in TcR V beta gene usage and imply that functional Mls-like determinants are presented by T cell blasts. The findings are discussed with respect to TcR-major histocompatibility complex interactions in allostimulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142455     DOI: 10.1002/eji.1830200605

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  Superantigens related to B cell hyperplasia.

Authors:  N M Ponzio; V K Tsiagbe; G J Thorbecke
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Anti-T-cell receptor V beta 6 breaks tolerance in Mlsa mice and induces production of anti-Mlsa antibodies.

Authors:  A Matossian-Rogers; L de Giorgi
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

3.  An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene.

Authors:  C L Miller; R Garner; V Paetkau
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  Cytokine treatment of macrophage suppression of T cell activation.

Authors:  Daniel Silberman; Amanda Bucknum; Megan Kozlowski; Robin Matlack; James Riggs
Journal:  Immunobiology       Date:  2009-02-26       Impact factor: 3.144

5.  The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein.

Authors:  A J Korman; P Bourgarel; T Meo; G E Rieckhof
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

6.  CD8+ T cell response to Mls-1a determinants involves major histocompatibility complex class II molecules.

Authors:  Y Chvatchko; H R MacDonald
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

7.  CD4 expression is differentially required for deletion of MLS-1a-reactive T cells.

Authors:  V A Wallace; A Rahemtulla; E Timms; J Penninger; T W Mak
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.